| Literature DB >> 26754747 |
Antoine R Baldassari1,2, Rebecca J Cleveland1, My-Linh N Luong1, Beth L Jonas1,3, Doyt L Conn4, Larry W Moreland5, S Louis Bridges6, Leigh F Callahan7,8,9.
Abstract
BACKGROUND: There is abundant evidence that low socioeconomic status (SES) is associated with worse health outcomes among people with Rheumatoid Arthritis (RA); however, the influence of socioeconomic disadvantage in early life has yet to be studied within that population.Entities:
Mesh:
Year: 2016 PMID: 26754747 PMCID: PMC4709946 DOI: 10.1186/s12891-016-0882-5
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Fig. 1Flow chart of CLEAR1 II participants included in this study. 1 Consortium for the Evaluation of African-Americans with Rheumatoid Arthritis (RA). 2 Covariates include age, gender, BMI, disease duration, cigarette smoking, methotrexate use and biologic agent use
Characteristics of CLEAR II participants included in the study (N = 516)
| Mean (SD) or Percent | |
|---|---|
| Participants (N)a | |
|
| |
| Age (years) | 54.7 (11.2) |
| Gender (% Female) | 89.5 |
| Currently smoking (%) | 23.3 |
| Disease duration (years) | 10.8 (9.5) |
| Total smoking (pack years) | 9.1 (16.2) |
|
| |
| Methotrexate or Leflunomide | 63.6 |
| Biological agents | 24.4 |
|
| |
| Less than or = HS | 47.5 |
| Homeownership | 56.0 |
| Parental education < HS | 55.2 |
| Parental homeownership | 43.2 |
|
| |
| Fatigue (VAS cm) | 6.0 (3.0) |
| Pain (VAS cm) | 6.3 (2.8) |
| Disability (HAQ) | 1.3 (0.7) |
| Helplessness (RAI) | 2.8 (1.0) |
CLEAR Consortium for the Longitudinal Evaluation of African-Americans with Rheumatoid Arthritis, SD Standard deviation
aDataset restricted to the 516 participants with complete data on SES and covariates: age, sex, body mass index, disease duration, smoking status, current methotrexate/leflunomide use, and current biologic agent use
Associations of participant and parental low-Socioeconomic status markers with self-reported health outcomes in CLEAR IIa
| Current educationb | Parental educationc | Current homeownershipd | Parent homeownershipd | LRT p vs. full | |
|---|---|---|---|---|---|
|
| |||||
| Fatigue (VAS cm) |
|
| 0.06 | ||
| Disability (HAQ) |
|
| 0.13 | ||
| Pain (VAS cm) |
| 0.06 (−0.15,0.27) | 0.20 | ||
| Helplessness (RAI) |
| 0.09 (−0.10,0.27) |
| ||
|
| |||||
| Fatigue (VAS cm) | 0.29 (−0.09,0.66) |
| 0.85 | ||
| Disability (HAQ) |
|
|
| ||
| Pain (VAS cm) |
| 0.58 (−0.04,1.19) |
| ||
| Helplessness (RAI) |
|
| 0.22 | ||
|
| |||||
| Fatigue (VAS cm) | 0.22 (−0.13,0.58) |
| 0.27 (−0.08,0.62) |
| |
| Disability (HAQ) |
|
|
|
| |
| Pain (VAS cm) |
| 0.08 (−0.14,0.29) |
| 0.40 (−0.24,1.04) | |
| Helplessness (RAI) |
| 0.10 (−0.08,0.29) |
|
|
CLEAR Consortium for the Longitudinal Evaluation of African-Americans with Rheumatoid Arthritis, HAQ Health Assessment Questionnaire, LRT Likelihood Ratio Test, VAS Visual analog scale (in centimeters), RAI Rheumatology Attitudes Index
Bolded results are statistically significant at the α = 0.05 level
aAdjusted for age; dataset restricted to the 516 participants with complete data on SES and covariates: age, sex, body mass index, disease duration, smoking status, current methotrexate/leflunomide use, and current biologic agent use
bParticipant low education: ≤HS, compared to high education (>HS)
cParental low education:
dNon-homeownership, compared to homeownership